Merck Sharp & Dohme Corp. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .

In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.

NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in Sutro Biopharma Inc (STRO). Other recent insider transactions involving Sutro Biopharma Inc (STRO) include a net sale of 27,041 shares made by Brunilda Shtylla , and a net sale of 12,185 shares made by Nicki Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of Sutro Biopharma Inc (STRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 39,226 shares of Sutro Biopharma Inc (STRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 39,226 shares.

Sutro Biopharma Inc (STRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in VYNE Therapeutics Inc (VYNE). Other recent insider transactions involving VYNE Therapeutics Inc (VYNE) include a net purchase of 13,000 shares made by Patrick G Lepore ,

In summary, during the past 3 months, insiders sold 0 shares of VYNE Therapeutics Inc (VYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of VYNE Therapeutics Inc (VYNE) were sold and 13,000 shares were bought by its insiders, resulting in a net purchase of 13,000 shares.

VYNE Therapeutics Inc (VYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in OpGen Inc (OPGN). Other recent insider transactions involving OpGen Inc (OPGN) include a net purchase of 5,245,603 shares made by ,

In summary, during the past 3 months, insiders sold 0 shares of OpGen Inc (OPGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,400,000 shares of OpGen Inc (OPGN) were sold and 7,645,603 shares were bought by its insiders, resulting in a net purchase of 5,245,603 shares.

OpGen Inc (OPGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Merck Sharp & Dohme Corp. made no insider transaction in BeiGene Ltd (ONC). Other recent insider transactions involving BeiGene Ltd (ONC) include a net sale of 120,245 shares made by John Oyler , a net sale of 15,269 shares made by Xiaobin Wu , and a net sale of 3,266 shares made by Chan Henry Lee .

In summary, during the past 3 months, insiders sold 18,969,628 shares of BeiGene Ltd (ONC) in total and bought 0 shares, with a net sale of 18,969,628 shares. During the past 18 months, 20,219,634 shares of BeiGene Ltd (ONC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 20,219,634 shares.

BeiGene Ltd (ONC)'s detailed insider trading history can be found in Insider Trading Tracker table.